News|Slideshows|June 17, 2026

Research Highlights from SNMMI 2026

Catch up on the latest imaging research from the recent SNMMI conference.

Take a look back at some of the most viewed research updates from the annual SNMMI conference. Topics ranged from preliminary findings with the alpha-emitting radioconjugate ATNM-400 for prostate cancer and the combination of CT attenuation correction mapping and AI for coronary artery calcium (CAC) risk stratification to significant upstaging with PSMA PET/CT in patients with osseous oligometastatic PCa. Review the slideshow below to see highlighted research updates from the recent SNMMI conference.

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related to this article

September 29th, 2026

ASTRO: What New Phase 3 Research Reveals About SBRT for Patients with Localized Prostate Cancer

For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.

September 28th, 2026

Can Brain MRI Surveillance Alone Be Advantageous in Monitoring Cognition for Patients with SCLC?

For patients with small cell lung cancer (SCLC), there was a 40 percent improvement in cognitive failure-free survival (CFFS) with brain MRI alone in comparison to the combination of brain MRI and prophylactic cranial irradiation (PCI), according to research presented at the ASTRO conference.

October 3rd, 2026

Emerging Research Insights and New Advances in Neuroradiology

Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.

October 2nd, 2026

MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?

Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.

October 1st, 2026

Current Perspectives on Integrating AI into Radiology

In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.

October 1st, 2026

Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA

Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?

September 30th, 2026

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1

In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.

September 30th, 2026

Top Five Radiology Content in September 2026

Catch up on the most-well viewed radiology content in September 2026.

Research Highlights from SNMMI 2026

Related to this article

Trending on Diagnostic Imaging

Emerging Research Insights and New Advances in Neuroradiology

MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?

FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection

Radiology and Building the Alzheimer’s Care Pathway of the Future

ASTRO: What New Phase 3 Research Reveals About SBRT for Patients with Localized Prostate Cancer